Provided by Tiger Fintech (Singapore) Pte. Ltd.

AIM ImmunoTech Inc.

9.21
+0.910010.96%
Post-market: 9.210.00000.00%19:52 EDT
Volume:87.17K
Turnover:910.13K
Market Cap:7.04M
PE:-0.37
High:10.38
Open:9.13
Low:8.50
Close:8.30
Loading ...

Argo Group Limited Concludes Tender Offer and Announces AIM Delisting

TIPRANKS
·
19 Feb

Hargreave Hale AIM VCT 1 Faces Challenging Start Amid Economic Uncertainty

TIPRANKS
·
17 Feb

Wellnex Life Launches $22.1 Million Entitlement Offer Ahead of AIM Listing

TIPRANKS
·
17 Feb

Argo Group Extends Tender Offer Deadline Amid AIM Delisting Plans

TIPRANKS
·
15 Feb

Hargreave Hale AIM VCT PLC Announces Share Allotment Under Dividend Reinvestment Scheme

TIPRANKS
·
14 Feb

Wellnex Life Receives AU$9 Million in Binding Commitments Amid Planned Dual Listing on London's AIM Market; Shares Plunge 19%

MT Newswires Live
·
14 Feb

Wellnex Life raises $9m ahead of proposed London Stock Exchange AIM listing

Small Caps
·
14 Feb

Wellnex Life secures $9m to propel dual listing on London’s AIM market

Stockheads
·
14 Feb

Wellnex Life Secures A$9 Million for AIM Listing Pursuit

TIPRANKS
·
14 Feb

Hargreave Hale AIM VCT Announces Share Purchase and Cancellation

TIPRANKS
·
13 Feb

Tribe Technology PLC to Delist from AIM and Go Private

TIPRANKS
·
12 Feb

AIM Vaccine Submits Clinical Trial Application for mRNA Shingles Vaccine to Chinese Regulator

MT Newswires Live
·
12 Feb

AIM ImmunoTech to not proceed with offering pursuant to registration statement

TIPRANKS
·
11 Feb

AIM ImmunoTech Announces That It Will Not Proceed With an Offering Pursuant to Its Registration Statement on Form S-1 Until After It Files Its Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2024

THOMSON REUTERS
·
11 Feb

Amati AIM VCT PLC Announces Share Buyback

TIPRANKS
·
11 Feb

AIM-listed companies stall on gender diversity

cityam
·
11 Feb

Argo Group to Delist from AIM Following Shareholder Approval

TIPRANKS
·
11 Feb

Gusbourne: Wine maker faces delisting from London’s AIM as shares plummet

cityam
·
10 Feb

Petra Capital Keeps Their Buy Rating on Ai-Media Technologies Limited (AIM)

TIPRANKS
·
10 Feb

AIM ImmunoTech announces follow-up clinical study of Ampligen with FluMist

TIPRANKS
·
07 Feb